Skip to content
Back to Investors
AC

Angel Co-Investment Fund

Government

Portfolio

2

companies

By category

  • BioTech£1.4M
  • MedTech£1.2M

By location

  • Cardiff£2.6M

Portfolio companies

Antiverse

Antiverse

Antiverse develops AI-designed therapeutic antibodies for challenging disease targets using computational platforms and in-house laboratories.

K

Kaydiar

Advanced footcare solutions created through customisable mesh technology.


Recent investments

£1.2M

The funding round combines backing from the Development Bank of Wales and Women Angels of Wales with grant support.

"We’re working hard to encourage more women to get involved with angel investing. Our support for Kaydiar is a great example of bringing together grant, angel and institutional funding to provide the resources to support the development of an innovative, early-stage company in Wales. Our syndicate is delighted to support Heather Smart and David Barton, two young podiatrists who are applying new technologies to improve patient outcomes in the footcare sector. We all look forward to working with Kaydiar to build a world class company."
— Sharon Pipe
Seed
£1.4M

The seed round was supported by a syndicate of investors including the Development Bank of Wales and the UKI2S Innovate Accelerator to fund platform development and laboratory expansion.

"Our investors recognise the potential of our AI-powered antibody drug discovery platform to provide a breakthrough in the industry. With our technology, it will be possible to develop drugs for difficult targets and ultimately reduce drug discovery timescales from years to weeks. In addition to platform development, the funding will enable us to invest in facilities and recruitment; we are grateful to our investors and Innovate UK for their continued support."
— Murat Tunaboylu, Co-Founder and CEO